Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials-Reference-Cited by-同舟云学术

Development of interim patient-reported outcome measures for the assessment of ulcerative colitis disease activity in clinical trials

Published:2015-09-21 Issue:10 Volume:42 Page:1200-1210
ISSN:0269-2813
Container-title:Alimentary Pharmacology & Therapeutics
language:en
Short-container-title:Aliment Pharmacol Ther

Author:

Jairath V.¹²,Khanna R.³⁴,Zou G. Y.³⁵,Stitt L.³,Mosli M.³⁴⁶,Vandervoort M. K.³,D'Haens G.³⁷,Sandborn W. J.³⁸,Feagan B. G.³⁴⁵,Levesque B. G.³⁸

Affiliation:

1. Translational Gastroenterology Unit; Nuffield Department of Medicine; University of Oxford; Oxford UK

2. Oxford Clinical Trials Research Unit; Oxford UK

3. Robarts Clinical Trials; University of Western Ontario; London ON Canada

4. Department of Medicine; University of Western Ontario; London ON Canada

5. Department of Epidemiology and Biostatistics; University of Western Ontario; London ON Canada

6. Department of Medicine; King Abdulaziz University; Jeddah Saudi Arabia

7. Inflammatory Bowel Disease Centre; Academic Medical Centre; Amsterdam The Netherlands

8. Division of Gastroenterology; University of California, San Diego; La Jolla CA USA

Funder

UK National Institute for Health Research

Publisher

Wiley

Subject

Pharmacology (medical),Gastroenterology,Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/apt.13408/fullpdf

Reference19 articles.

1. A review of activity indices and efficacy endponts for clinical trials of medical therapy in adults with ulcerative colitis;D'Haens;Gastroenterology,2007

2. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis. A randomized study;Schroeder;N Engl J Med,1987

3. 5-Aminosalicylic acid enemas in treatment of distal ulcerative colitis and proctitis in Canada;Sutherland;Dig Dis Sci,1987

4. Infliximab induction and maintenance therapy for ulcerative colitis;Rutgeerts;N Engl J Med,2005

5. Patient-reported outcomes are changing the landscape in oncology care: challenges and opportunities for payers;Zagadailov;Am Health Drug Benefit,2013

Cited by 115 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Intensified anti-TNF treatment downregulates the phenotype in ulcerative colitis: a 13-year prospective follow-up study;Frontiers in Gastroenterology;2024-01-24

2. Endoscopic healing is associated with a reduced risk of biologic treatment failure in patients with ulcerative colitis;Scientific Reports;2024-01-03

3. Self-Management assistance for recommended treatment (SMART) IBD app randomized control trial in adolescents with IBD: Design and methodology;Health Care Transitions;2024

4. A Core Outcome Set for Inflammatory Bowel Diseases: Development and Recommendations for Implementation in Clinical Practice Through an International Multi-stakeholder Consensus Process;Journal of Crohn's and Colitis;2023-11-29

5. Inflammatory bowel diseases patients suffer from significant low levels and barriers to physical activity: The “BE-FIT-IBD” study;World Journal of Gastroenterology;2023-11-07